Huntington National Bank’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4308 |
|
|
2025
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4275 |
|
|
2025
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4237 |
|
|
2025
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4267 |
|
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4299 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4273 |
|
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4259 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4188 |
|
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4057 |
|
|
2023
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4002 |
|
|
2023
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3946 |
|
|
2023
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 3858 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 3692 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 3616 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2593 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2597 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2525 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2453 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2181 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2068 |
|
|
2021
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1959 |
|
|
2020
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1935 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1879 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1885 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1982 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1991 |
|
|
2019
Q3 | $0 | Buy |
+1
| New | +$7 | ﹤0.01% | 1897 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1926 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1924 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1980 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1980 |
|
|
2016
Q2 | – | Sell |
-76
| Closed | -$56K | – | 1739 |
|
|
2016
Q1 | $56K | Buy |
+76
| New | +$7.59K | ﹤0.01% | 1083 |
|
|
2015
Q3 | – | Sell |
-75
| Closed | -$71K | – | 1823 |
|
|
2015
Q2 | $71K | Sell |
75
-1
| -1% | -$818 | ﹤0.01% | 1017 |
|
|
2015
Q1 | $56K | Sell |
76
-16
| -17% | -$12K | ﹤0.01% | 1087 |
|
|
2014
Q4 | $73K | Buy |
+92
| New | +$49.5K | ﹤0.01% | 1007 |
|
Huntington National Bank's TTPH Position: Q1 2026 in Review
Huntington National Bank held its Tetraphase Pharmaceuticals, Inc. (TTPH) position steady in Q1 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4308.
Huntington National Bank first reported a position in TTPH in Q4 2014 and has held it in 31 quarters since. The position peaked at $73K in Q4 2014. 1 fund tracked by Wall St. Rank holds TTPH as of Q1 2026.
- Huntington National Bank held 1 share of Tetraphase Pharmaceuticals, Inc. worth $0 as of Q1 2026.
- Huntington National Bank left its Tetraphase Pharmaceuticals, Inc. share count unchanged in Q1 2026.
- Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #4308 holding.
- Huntington National Bank first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and has held it in 31 quarters since.
- Huntington National Bank's Tetraphase Pharmaceuticals, Inc. position peaked at $73K in Q4 2014.
- 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.